Bluejay Diagnostics, Inc. Payments of Financing Costs
Bluejay Diagnostics, Inc. (BJDX) reported Payments of Financing Costs of $2.12 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-12
- Bluejay Diagnostics, Inc. payments of financing costs for the quarter ending 2026-06-30 was $1.07K, a 7.65% increase year-over-year.
- Bluejay Diagnostics, Inc. payments of financing costs for the quarter ending 2026-03-31 was $1.05K, a 6.70% increase year-over-year.
- Bluejay Diagnostics, Inc. payments of financing costs for the quarter ending 2025-12-31 was $1.03K, a 7.27% increase year-over-year.
- Bluejay Diagnostics, Inc. payments of financing costs for the quarter ending 2025-09-30 was $1.01K, a 7.18% increase year-over-year.
- Bluejay Diagnostics, Inc. payments of financing costs for fiscal 2025 was $4.03K, a 7.27% increase from fiscal 2024.
- Bluejay Diagnostics, Inc. payments of financing costs for fiscal 2024 was $3.75K, a 21.91% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. payments of financing costs for fiscal 2023 was $4.81K, a 500.12% increase from fiscal 2022.
- Bluejay Diagnostics, Inc. payments of financing costs for fiscal 2022 was $801.00, a 99.56% decline from fiscal 2021.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 3 month as first filed | Payments of Financing Costs 6 month | Payments of Financing Costs 6 month as first filed | Payments of Financing Costs 9 month | Payments of Financing Costs 9 month as first filed | Payments of Financing Costs 12 month | Payments of Financing Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.12K 10-Q · filed 2026-08-12 | $3.15K derived: sum of 3 quarters · filed 2026-08-12 | $4.17K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $1.05K 10-Q · filed 2026-05-07 | $2.08K derived: sum of 2 quarters · filed 2026-05-07 | $3.10K derived: sum of 3 quarters · filed 2026-05-07 | $4.09K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $1.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.05K derived: sum of 2 quarters · filed 2026-03-06 | $3.04K derived: sum of 3 quarters · filed 2026-08-12 | $4.03K 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | $1.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.01K derived: sum of 2 quarters · filed 2026-08-12 | $2.99K 10-Q · filed 2025-11-07 | $3.96K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $994.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.98K 10-Q · filed 2026-08-12 | $2.94K derived: sum of 3 quarters · filed 2026-08-12 | $3.89K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $985.00 10-Q · filed 2026-05-07 | $1.95K derived: sum of 2 quarters · filed 2026-05-07 | $2.90K derived: sum of 3 quarters · filed 2026-05-07 | $3.83K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $963.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $1.91K derived: sum of 2 quarters · filed 2026-03-06 | $2.84K derived: sum of 3 quarters · filed 2026-03-06 | $3.75K 10-K · filed 2026-03-06 | $4.81K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $947.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.88K derived: sum of 2 quarters · filed 2025-11-07 | $2.79K 10-Q · filed 2025-11-07 | $3.60K 10-Q · filed 2024-11-07 | $3.99K derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $930.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.84K 10-Q · filed 2025-08-07 | $2.40K 10-Q · filed 2024-08-14 | $3.05K derived: sum of 3 quarters · filed 2025-08-07 | $4.25K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $914.00 10-Q · filed 2025-05-13 | $4.81K 10-Q · filed 2024-05-15 | $2.12K derived: sum of 2 quarters · filed 2025-05-13 | $3.32K derived: sum of 3 quarters · filed 2025-05-13 | $4.52K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $1.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.40K derived: sum of 2 quarters · filed 2025-03-31 | $3.60K derived: sum of 3 quarters · filed 2025-03-31 | $4.81K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.40K derived: sum of 2 quarters · filed 2024-11-07 | $3.60K 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | $1.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.40K 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | $1.20K 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | $801.00 10-K · filed 2024-03-28 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $183.19K 10-K · filed 2022-03-10 | ||||||
| 2021-09-30 | $183.19K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |